Concepedia

Pd Model Building

PD Model Building is a pharmacometric modeling activity that constitutes the development and refinement of pharmacodynamic models to characterize the quantitative relationship between drug exposure and therapeutic or adverse effects, distinguished by its focus on structuring, parameterizing, and validating mathematical representations of biological responses to drug concentrations.

141

Publications

6.9K

Citations

642

Authors

282

Institutions

Publications per year

2017–2026

46

Parents

Publications

141

Marketing Decision Making: A Model Building Approach

Adel I. El‐Ansary, Philip Kotler · Journal of Marketing · 1971 · 552 citations

, , +13

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model

Lars Kuepfer, Christoph Niederalt, Thomas Wendl et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 398 citations · Full text

, , +17

Marketing Decision Making: A Model Building Approach

Charles B. Weinberg, Gary L. Lilien, Philip Kotler · Journal of Marketing Research · 1984 · 294 citations

, , +13

Drug–Target Kinetics in Drug Discovery

Peter J. Tonge · ACS Chemical Neuroscience · 2017 · 289 citations · Full text

, , +17

Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

George L. Drusano, Sandra L. Preston, C. Hardalo et al. · Antimicrobial Agents and Chemotherapy · 2001 · 242 citations · Full text

, , +17

1–5 of 141

Authors

642

  1. DB
    Dominique Barbolosi

    Inserm, France

    3 publications · 123 citations

    3

    h-index

  2. PJ
    Peter J. Tonge

    Stony Brook University, United States

    2 publications · 317 citations

    2

    h-index

  3. DK
    Dhaval K. Shah

    University at Buffalo, State University of New York, United States

    2 publications · 76 citations

    2

    h-index

  4. GR
    Gerald Rhodes

    New Frontier, United States

    2 publications · 241 citations

    2

    h-index

  5. SL
    Sabrina L. Peczonczyk

    University of Michigan, United States

    2 publications · 62 citations

    2

    h-index

1–5 of 642

Institutions

282

  1. University at Buffalo, State University of New York

    Buffalo, United States

    5 h-index

    11 publications

    282 citations

  2. Uppsala University

    Uppsala, Sweden

    4 h-index

    14 publications

    636 citations

  3. University of Florida

    Gainesville, United States

    4 h-index

    6 publications

    541 citations

  4. Center for Drug Evaluation and Research

    Silver Spring, United States

    4 h-index

    21 publications

    954 citations

  5. Leiden University

    Leiden, The Netherlands

    3 h-index

    3 publications

    53 citations

  6. Novartis (United States)

    New York, United States

    3 h-index

    3 publications

    148 citations

  7. Novartis (Switzerland)

    Basel, Switzerland

    3 h-index

    7 publications

    461 citations

  8. AstraZeneca (United Kingdom)

    Cambridge, United Kingdom

    3 h-index

    6 publications

    221 citations

1–8 of 282

Venues

  1. British Journal of Clinical Pharmacology

    BJCP · 7 publications · 239 citations

    7

    h-index

  2. CPT Pharmacometrics & Systems Pharmacology

    PSP · 4 publications · 466 citations

    4

    h-index

  3. 4

    h-index

  4. Journal of Pharmaceutical Sciences

    4 publications · 134 citations

    4

    h-index

  5. The Journal of Clinical Pharmacology

    3 publications · 264 citations

    3

    h-index

1–5